SUNY
Polygenic Risk Scores for Neuropsychiatric Conditions in Civilians Are Generalizable to Veterans
Data from the US Million Veteran Program indicates that schizophrenia PRS developed with civilian data can identify veterans at risk of the condition despite differences between the cohorts.
Biotia Raises $8M in Series A Financing
The New York-based startup said the funding will be used to expand its technical capabilities, regulatory compliance, and marketing reach.
Quadrant Biosciences Wins $2.3M NIH Grant to Develop Saliva Test for Concussion
The company and its collaborators previously published a study linking saliva concentrations of multiple microRNAs with concussion duration and symptoms in children.
New York Governor Plans Consortium for Alzheimer's Disease Genetic Research
The five-year initiative aims to collect and disseminate genomic data on 1 million people with Alzheimer's disease or who are at risk for the condition.
A Phase II trial is pursuing molecularly targeted treatments for CUP as a different Phase III trial failed to find benefit for expression-based primary site therapies.